Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population

BACKGROUND: About 5–10% of breast/ovarian cancers are hereditary. However, for a large proportion of cases (around 50%), the genetic cause remains unknown. These cases are grouped in a separated BRCAX category. The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Felicio, Paula Silva, Bidinotto, Lucas Tadeu, Melendez, Matias Eliseo, Grasel, Rebeca Silveira, Campacci, Natalia, Galvão, Henrique C.R., Scapulatempo-Neto, Cristovam, Dufloth, Rozany Mucha, Evangelista, Adriane Feijó, Palmero, Edenir Inêz
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007956/
https://ncbi.nlm.nih.gov/pubmed/29938003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25537
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak